Effect of levetiracetam on time to high-dose methotrexate clearance in patients with hematologic malignancies

High-dose methotrexate (HDMTX) is a commonly used treatment for hematologic malignancies involving the central nervous system (CNS). Two case reports described possible delayed methotrexate clearance in patients receiving concurrent levetiracetam while a retrospective cohort study did not find this...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Pharmacol
Hoofdauteurs: Lou, Uvette, Kwok, Jamie, Nguyen, Thu Anne, Zhou, Allen, Luk, Samantha O.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004859/
https://ncbi.nlm.nih.gov/pubmed/31729053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1544
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items